Navigation Links
Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
Date:1/18/2010

RANCHO SANTA MARGARITA, Calif., Jan. 18 /PRNewswire/ -- For humans, sunlight and vitamin D is critically important for the development, growth, and maintenance of a healthy body, from birth until death. "Humans make thousands of units of vitamin D within minutes of whole body exposure to sunlight. From what we know of nature, it is unlikely such a system evolved by chance," states Dr. John Cannell, Executive Director, Vitamin D Council. According to the Vitamin D Council, current research has implicated sunlight and vitamin D deficiency as a major factor in the pathology of at least 17 varieties of cancer as well as heart disease, stroke, hypertension, autoimmune diseases, diabetes, depression, chronic pain, osteoarthritis, osteoporosis, muscle weakness, muscle wasting, birth defects, periodontal disease, and more. The September 2009 issue of The American Journal of Medicine (Volume 122, Issue 9) has an extensive review of the research on the benefits of vitamin D and points to fascinating "life extension" potential. The Journal notes that all cause mortality is decreased by at least 7% in a meta-analysis of 18 randomized trials of vitamin D supplementation.

For decades, consumers have been the target of a disinformation campaign from conventional medicine and the pharmaceutical industry that created a fear of sunshine. They have literally scared the daylight out of us! Therefore, most people either intentionally or unintentionally avoid the sun -- or smear on sunscreens that block the beneficial wavelengths that produce one's natural supply of vitamin D from direct exposure to bright midday sun. Now more than ever in this age of information, millions of people have unwittingly become "contemporary cave-dwellers," living and working indoors. This dramatic reduction of natural light exposure -- that human DNA is programmed to assimilate -- and its associated disturbance to vital circadian rhythms, has contributed to many health related issues. The late Dr. John Ott, renowned photo biologist and father of full-spectrum light, had coined this adverse health phenomenon "mal-illumination." Like malnutrition, mal-illumination deprives one of a level of nutrients and rhythmic stimulation that is essential for living as healthy humans. Everyone knows the sun rises and sets every day -- this essential cycle sets the basic rhythm of life. Unknowingly, millions of people are "out of rhythm with nature" and suffer from chronic mal-illumination...a root cause of most disease.

Humans are photobiotic "solar beings" -- all humans are absolutely dependent on the absorption of vital solar radiation. Noble Prize Laureate Dr. Szent-Gyorgi describes the essential life process as, "A little electrical current sent to us by the sunshine." Without light there is no health. "We are human photocells whose ultimate biological nutrient is sunlight," states bioLight Group (bLG) CEO, Ken Ceder. "Every metabolic process, from enzyme reactions to muscular movements to the digestion of food and the burning of fat, is an electro-chemical biological process regulated and augmented by sunlight energy. A reduction of natural light energy causes a slowdown in these processes leading to decreased metabolism, reduced burning of fat, reduced vitality and compromised immunity."

Whether one is suffering or feeling generally "fine" -- more natural light during the day will reduce the risk of mal-illumination and also elevate mood and reduce fatigue for the healthy and sick, the young and old. The bioLight Group is pleased to offer a free e-Book, "Mal-illumination... the silent epidemic," and share clinical research that will naturally complement and enhance people's wellness experience.

bLG is a health science, research and development innovator of light therapy devices and wellness applications since 1987 and serves as a catalyst for raising awareness of Mal-illumination...the silent epidemic.

For a free e-Book and more information, please visit http://www.malillumination.org/ebook.html

Contact: Ken Ceder at 949-713-6446 or research@malillumination.org

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE bioLight Group

RELATED LINKS
http://www.malillumination.org/ebook.html

'/>"/>

SOURCE bioLight Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
2. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
3. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
4. alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both
5. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
6. ATS Medical Expands Open Pivot Heart Valve Offerings
7. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
10. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
11. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences announced ... has been appointed as a Certified Service ... IsoFlux system will be used in Genetracer Biotech,s novel ... lung and colon cancer, with plans to move to ... is utilizing Fluxion,s IsoFlux System to isolate, recover, and ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... procedures can be safely completed in an ambulatory surgery center (ASC) with satisfactory ... procedures and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):